The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of interdisciplinary sarcoma board evaluation on treatment outcome of primary soft-tissue sarcoma patients.
 
Jana Kaethe Striefler
No Relationships to Disclose
 
Annika Strönisch
No Relationships to Disclose
 
Daniel Rau
No Relationships to Disclose
 
David Kaul
No Relationships to Disclose
 
Georgios Koulaxouzidis
No Relationships to Disclose
 
Robert Oellinger
Research Funding - Chiesi (Inst); Sanofi (Inst)
 
Maximilian Von Laffert
Consulting or Advisory Role - Roche
Speakers' Bureau - Roche
 
Frederik Maximilian Schäfer
No Relationships to Disclose
 
Ulrich Keilholz
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; MSD; Novartis; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; MSD; Pfizer
 
Lars Bullinger
Speakers' Bureau - Jazz Pharmaceuticals; Novartis; Pfizer; Sanofi; Seagen
Research Funding - Bayer; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Daiichi Sankyo; Roche
 
Sven Märdian
Consulting or Advisory Role - aap, Exactech
 
Anne Flörcken
Travel, Accommodations, Expenses - Ipsen; PharmaMar